Pages

▼
Showing posts with label Versant Ventures. Show all posts
Showing posts with label Versant Ventures. Show all posts
Friday, November 01, 2013

Single, Early-Stage Financings of the Fortnight Seeks Attractive Exit Correlation

›
One month ago, as the government shut itself partially down, this column wondered if the IPO window might undergo a similar fate. Sinc...
Friday, April 05, 2013

Versant Looks For "Off-The-Beaten-Path" Deals In Canada, Europe

›
Versant Ventures has been deepening its commitment to international expansion lately. The firm is replicating its San Diego-based discove...
Wednesday, December 12, 2012

Alliance Deal of the Year Nominee: Versant/Roche/Inception 3

›
It's time for the IN VIVO Blog's Fifth Annual Deal of the Year! competition. Once again we're presenting awards in three cate...
Thursday, October 18, 2012

Financings of the Fortnight Goes Around The Middle Man

›
This fortnight’s theme is DIY. That’s shorthand for “do it yourself,” in case you’re one of those people who has only used a hammer to pr...
Wednesday, October 10, 2012

Say What: Inception Inks Hearing-Loss Deal With Roche

›
Inception Sciences, the discovery-stage biotech firm-slash-incubator created from the ground up to spin out assets in a buyer-friendly ...
1 comment:
Wednesday, December 14, 2011

2011 Exit/Financing of the Year Nominee: Quanticel

›
It's time for the IN VIVO Blog's Fourth Annual Deal of the Year! competition. This year we're once again presenting awards in th...
Thursday, February 25, 2010

Washing Away Post-Deal Blues With A De-Sanofizer

›
There's nothing like a gathering of insiders to generate some candid chat about the latest doings, and that's what you can hear at t...